Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis.
Alexis LlewellynMark SimmondsWill L IrvingGinny BruntonAmanda J SowdenPublished in: Hepatology, medicine and policy (2016)
cART was associated with significantly lower liver-related mortality in patients co-infected with HIV and HCV. Evidence of a positive association between cART and/or ARV monotherapy and liver-disease progression was less clear, but there was no evidence to suggest that the absence of antiretroviral therapy was preferable.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv positive
- hiv aids
- hiv infected patients
- hepatitis c virus
- end stage renal disease
- newly diagnosed
- ejection fraction
- prognostic factors
- clinical trial
- men who have sex with men
- cardiovascular disease
- randomized controlled trial
- risk factors
- patient reported outcomes
- south africa